Literature DB >> 10919056

Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach.

M Baba1, S Hokita, S Natsugoe, T Miyazono, M Shimada, S Nakano, S Takao, T Aikou.   

Abstract

BACKGROUND/AIMS: According to current TNM classification, paraaortic nodes involvement in gastric cancer is now distant metastasis. Anatomically, however, proximal gastric cancer may drain preferentially to the left-paraaortic area which represents a regional lymph-node basin.
METHODOLOGY: Seventy-five patients who underwent an extended gastrectomy with paraaortic lymphadenectomy for advanced carcinoma of the upper-third of the stomach were retrospectively studied.
RESULTS: Of the 75 patients, 55 (73.3%) were positive for nodal metastasis and 21 (28.0%) had paraaortic nodes involvement. Paraaortic nodes involvement tended to be left-sided (the left side of the aorta around the left renal vein) and its incidence did not increase as the overall number of infiltrated nodes increased. Five (23.8%) of the 21 patients with paraaortic nodes involvement did not have nodal metastases in the paraceliac area. Overall survival was not different whether or not paraaortic nodes involvement was present, but was dependent on the overall number of infiltrated nodes (viz. 10 vs. > 10). Eight (22.2%) of 36 patients with 1-10 infiltrated nodes had PNI, with a 5-year survival rate of 46.9%.
CONCLUSIONS: Removal of lymph nodes around the left renal vein should be included during extended gastrectomy in patients with advanced carcinoma of the upper-third of the stomach. Left-paraaortic lymphadenectomy may benefit such patients if the overall number of infiltrated nodes is low (viz. 10).

Entities:  

Mesh:

Year:  2000        PMID: 10919056

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.

Authors:  Zhen Wang; Jun-Qiang Chen; Yun-Fei Cao
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 2.  Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.

Authors:  Valentina Mengardo; Maria Bencivenga; Jacopo Weindelmayer; Michele Pavarana; Simone Giacopuzzi; Giovanni de Manzoni
Journal:  Updates Surg       Date:  2018-05-30

3.  Is the length of esophageal invasion only associated with mediastinal nodal metastasis from adenocarcinoma of the esophagogastric junction (Siewert type II and III) after neo-adjuvant chemoradiotherapy?

Authors:  Shinji Mine
Journal:  J Thorac Dis       Date:  2019-10       Impact factor: 2.895

Review 4.  Lymph node dissection in the resection of gastric cancer: review of existing evidence.

Authors:  Yutaka Tanizawa; Masanori Terashima
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

5.  D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer.

Authors:  Mehmet Mahir Ozmen; Baris Zulfikaroglu; Fusun Ozmen; Munevver Moran; Necdet Ozalp; Selda Seckin
Journal:  Turk J Surg       Date:  2020-12-08

Review 6.  Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.

Authors:  Andrea Giuliani; Michelangelo Miccini; Luigi Basso
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

7.  Lymph node dissection in curative gastrectomy for advanced gastric cancer.

Authors:  Shigeyuki Tamura; Atsushi Takeno; Hirofumi Miki
Journal:  Int J Surg Oncol       Date:  2011-06-14

8.  Is There Any Role for D3 Lymphadenectomy in Gastric Cancer?

Authors:  Gerassimos N Douridas; Stefanos K Pierrakakis
Journal:  Front Surg       Date:  2018-03-22

9.  A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Authors:  Yan Wang; Yi-yi Yu; Wei Li; Yi Feng; Jun Hou; Yuan Ji; Yi-hong Sun; Kun-tang Shen; Zhen-bin Shen; Xin-yu Qin; Tian-shu Liu
Journal:  Cancer Chemother Pharmacol       Date:  2014-04-21       Impact factor: 3.333

10.  Questionnaire survey regarding the current status of super-extended lymph node dissection in Japan.

Authors:  Shinji Morita; Takeo Fukagawa; Hisataka Fujiwara; Hitoshi Katai
Journal:  World J Gastrointest Oncol       Date:  2016-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.